MRNA
NASDAQ · Biotechnology
Moderna Inc
$54.35
+5.81 (+11.97%)
Performance
1D
—
1W
—
1M
—
3M
+29.56%
6M
+119.51%
1Y
+124.12%
YTD
+76.12%
Open$49.00
Previous Close$48.54
Day High$57.78
Day Low$48.98
52W High$59.55
52W Low$22.28
Volume—
Avg Volume6.14M
Market Cap21.57B
P/E Ratio—
EPS$-8.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.98
Above
SMA 200
$29.64
Above
RSI (14)
57.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
30 analysts
Price Target
+175.0% upside
Current
$54.35
$54.35
Target
$149.45
$149.45
$89.97
$149.45 avg
$212.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.98B | 4.26B | 2.23B |
| Net Income | -2,878,486,025 | -5,564,083,811 | -285,156,561 |
| Profit Margin | -145.2% | -137.9% | -12.8% |
| EBITDA | -2,909,078,247 | -5,935,619,275 | -355,384,473 |
| Free Cash Flow | — | — | -237,052,091 |
| Rev Growth | -53.4% | -53.4% | +3.0% |
| Debt/Equity | 0.07 | 0.07 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |